4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0000921895-20-002547
Options or other derivatives
- Chief Executive Officer acquired 9,730,539 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DUGGAN ROBERT W · Chief Executive Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-02 | Grant or award : show line 1 in the form Common Stock | +9,730,539 | 9,730,539 | D |
Loading xslF345X03/form412566002_10062020.xml…